One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry

BackgroundCardiogenic shock (CS) is the most severe form of heart failure (HF), resulting in high early and long-term mortality. Characteristics of CS secondary to supraventricular tachycardia (SVT) are poorly reported. Based on a large registry of unselected CS, we aimed to compare 1-year outcomes...

Full description

Bibliographic Details
Main Authors: Miloud Cherbi, Eric Bonnefoy, Nicolas Lamblin, Edouard Gerbaud, Laurent Bonello, François Roubille, Bruno Levy, Sebastien Champion, Pascal Lim, Francis Schneider, Meyer Elbaz, Hadi Khachab, Jeremy Bourenne, Marie-France Seronde, Guillaume Schurtz, Brahim Harbaoui, Gerald Vanzetto, Nicolas Combaret, Vincent Labbe, Benjamin Marchandot, Benoit Lattuca, Caroline Biendel-Picquet, Guillaume Leurent, Etienne Puymirat, Philippe Maury, Clément Delmas
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1167738/full
_version_ 1797692724562886656
author Miloud Cherbi
Miloud Cherbi
Eric Bonnefoy
Nicolas Lamblin
Edouard Gerbaud
Edouard Gerbaud
Laurent Bonello
Laurent Bonello
Laurent Bonello
François Roubille
Bruno Levy
Sebastien Champion
Pascal Lim
Pascal Lim
Francis Schneider
Meyer Elbaz
Meyer Elbaz
Hadi Khachab
Jeremy Bourenne
Marie-France Seronde
Guillaume Schurtz
Brahim Harbaoui
Brahim Harbaoui
Gerald Vanzetto
Nicolas Combaret
Vincent Labbe
Benjamin Marchandot
Benoit Lattuca
Caroline Biendel-Picquet
Caroline Biendel-Picquet
Guillaume Leurent
Etienne Puymirat
Etienne Puymirat
Philippe Maury
Philippe Maury
Clément Delmas
Clément Delmas
Clément Delmas
author_facet Miloud Cherbi
Miloud Cherbi
Eric Bonnefoy
Nicolas Lamblin
Edouard Gerbaud
Edouard Gerbaud
Laurent Bonello
Laurent Bonello
Laurent Bonello
François Roubille
Bruno Levy
Sebastien Champion
Pascal Lim
Pascal Lim
Francis Schneider
Meyer Elbaz
Meyer Elbaz
Hadi Khachab
Jeremy Bourenne
Marie-France Seronde
Guillaume Schurtz
Brahim Harbaoui
Brahim Harbaoui
Gerald Vanzetto
Nicolas Combaret
Vincent Labbe
Benjamin Marchandot
Benoit Lattuca
Caroline Biendel-Picquet
Caroline Biendel-Picquet
Guillaume Leurent
Etienne Puymirat
Etienne Puymirat
Philippe Maury
Philippe Maury
Clément Delmas
Clément Delmas
Clément Delmas
author_sort Miloud Cherbi
collection DOAJ
description BackgroundCardiogenic shock (CS) is the most severe form of heart failure (HF), resulting in high early and long-term mortality. Characteristics of CS secondary to supraventricular tachycardia (SVT) are poorly reported. Based on a large registry of unselected CS, we aimed to compare 1-year outcomes between SVT-triggered and non-SVT-triggered CS.MethodsFRENSHOCK is a French prospective registry including 772 CS patients from 49 centers. For each patient, the investigator could report 1–3 CS triggers from a pre-established list (ischemic, mechanical complications, ventricular/supraventricular arrhythmia, bradycardia, iatrogenesis, infection, non-compliance, and others). In this study, 1-year outcomes [rehospitalizations, mortality, heart transplantation (HTx), ventricular assist devices (VAD)] were analyzed and adjusted for independent predictive factors.ResultsAmong 769 CS patients included, 100 were SVT-triggered (13%), of which 65 had SVT as an exclusive trigger (8.5%). SVT-triggered CS patients exhibited a higher proportion of male individuals with a more frequent history of cardiomyopathy or chronic kidney disease and more profound CS (biventricular failure and multiorgan failure). At 1 year, there was no difference in all-cause mortality (43% vs. 45.3%, adjusted HR 0.9 (95% CI 0.59–1.39), p = 0.64), need for HTx or VAD [10% vs. 10%, aOR 0.88 (0.41–1.88), p = 0.74], or rehospitalizations [49.4% vs. 44.4%, aOR 1.24 (0.78–1.98), p = 0.36]. Patients with SVT as an exclusive trigger presented more 1-year rehospitalizations [52.8% vs. 43.3%, aOR 3.74 (1.05–10.5), p = 0.01].ConclusionSVT is a frequent trigger of CS alone or in association in more than 10% of miscellaneous CS cases. Although SVT-triggered CS patients were more comorbid with more pre-existing cardiomyopathies and HF incidences, they presented similar rates of mortality, HTx, and VAD at 1 year, arguing for a better overall prognosis.Clinical Trial Registrationhttps://clinicaltrials.gov, identifier: NCT02703038.
first_indexed 2024-03-12T02:32:44Z
format Article
id doaj.art-4e9cab32223c4b198c22e913199a91a7
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-12T02:32:44Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-4e9cab32223c4b198c22e913199a91a72023-09-05T06:53:51ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-09-011010.3389/fcvm.2023.11677381167738One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registryMiloud Cherbi0Miloud Cherbi1Eric Bonnefoy2Nicolas Lamblin3Edouard Gerbaud4Edouard Gerbaud5Laurent Bonello6Laurent Bonello7Laurent Bonello8François Roubille9Bruno Levy10Sebastien Champion11Pascal Lim12Pascal Lim13Francis Schneider14Meyer Elbaz15Meyer Elbaz16Hadi Khachab17Jeremy Bourenne18Marie-France Seronde19Guillaume Schurtz20Brahim Harbaoui21Brahim Harbaoui22Gerald Vanzetto23Nicolas Combaret24Vincent Labbe25Benjamin Marchandot26Benoit Lattuca27Caroline Biendel-Picquet28Caroline Biendel-Picquet29Guillaume Leurent30Etienne Puymirat31Etienne Puymirat32Philippe Maury33Philippe Maury34Clément Delmas35Clément Delmas36Clément Delmas37Intensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, FranceInstitute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1048, National Institute of Health and Medical Research (INSERM), Toulouse, FranceIntensive Cardiac Care Unit, Lyon Brom University Hospital, Lyon, FranceUrgences et Soins Intensifs de Cardiologie, CHU Lille, University of Lille, Inserm U1167, Lille, FranceIntensive Cardiac Care Unit and Interventional Cardiology, Hôpital Cardiologique du Haut Lévêque, Pessac, FranceBordeaux Cardio-Thoracic Research Centre, U1045, Bordeaux University, Hôpital Xavier Arnozan, Pessac, FranceCardiology Department, Hopital Nord, AP-HM, Aix-Marseille Université, Marseille, FranceIntensive Care Unit, Department of Cardiology, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, FranceMediterranean Association for Research and Studies in Cardiology (MARS Cardio), Marseille, France0Cardiology Department, PhyMedExp, Université de Montpellier, INSERM, CNRS, INI-CRT, CHU de Montpellier, Montpellier, France1Réanimation Médicale Brabois, CHRU Nancy, Vandoeuvre-les Nancy, France2Anesthesiology and Intensive Care Department, Clinique de Parly 2, Ramsay Générale de Santé, Le Chesnay, France3Univ Paris Est Créteil, INSERM, IMRB, Créteil, France4Cardiology Department, AP-HP, Hôpital Universitaire Henri-Mondor, Service de Cardiologie, Créteil, France5Médecine Intensive-Réanimation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, FranceIntensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, FranceInstitute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1048, National Institute of Health and Medical Research (INSERM), Toulouse, France6Intensive Cardiac Care Unit, Cardiology Department, CH d'Aix-en-Provence, Aix-en-Provence, France7Service de Réanimation des Urgences, AP-HM, Hôpital de La Timone, Marseille, France8Service de Cardiologie CHU, Besançon, FranceUrgences et Soins Intensifs de Cardiologie, CHU Lille, University of Lille, Inserm U1167, Lille, France9Cardiology Department, Hôpital Croix-Rousse and Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France0University of Lyon, CREATIS, UMR5220, INSERM U1044, INSA-15, Lyon, France1Department of Cardiology, Hôpital de Grenoble, La Tronche, France2Department of Cardiology, CHU Clermont-Ferrand, CNRS, Université Clermont Auvergne, Clermont-Ferrand, France3Medical Intensive Care Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Tenon,Paris, France4Université de Strasbourg, Pôle D'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France5Department of Cardiology, Nîmes University Hospital, Montpellier University, Nîmes, FranceIntensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, FranceInstitute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1048, National Institute of Health and Medical Research (INSERM), Toulouse, France6Department of Cardiology, CHU Rennes, Inserm, LTSI—UMR 1099, Univ Rennes 1, Rennes, France7Department of Cardiology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France8Université de Paris, Paris, FranceIntensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, FranceInstitute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1048, National Institute of Health and Medical Research (INSERM), Toulouse, FranceIntensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, FranceInstitute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1048, National Institute of Health and Medical Research (INSERM), Toulouse, France9REICATRA, Institut Saint Jacques, CHU de Toulouse, ToulouseFranceBackgroundCardiogenic shock (CS) is the most severe form of heart failure (HF), resulting in high early and long-term mortality. Characteristics of CS secondary to supraventricular tachycardia (SVT) are poorly reported. Based on a large registry of unselected CS, we aimed to compare 1-year outcomes between SVT-triggered and non-SVT-triggered CS.MethodsFRENSHOCK is a French prospective registry including 772 CS patients from 49 centers. For each patient, the investigator could report 1–3 CS triggers from a pre-established list (ischemic, mechanical complications, ventricular/supraventricular arrhythmia, bradycardia, iatrogenesis, infection, non-compliance, and others). In this study, 1-year outcomes [rehospitalizations, mortality, heart transplantation (HTx), ventricular assist devices (VAD)] were analyzed and adjusted for independent predictive factors.ResultsAmong 769 CS patients included, 100 were SVT-triggered (13%), of which 65 had SVT as an exclusive trigger (8.5%). SVT-triggered CS patients exhibited a higher proportion of male individuals with a more frequent history of cardiomyopathy or chronic kidney disease and more profound CS (biventricular failure and multiorgan failure). At 1 year, there was no difference in all-cause mortality (43% vs. 45.3%, adjusted HR 0.9 (95% CI 0.59–1.39), p = 0.64), need for HTx or VAD [10% vs. 10%, aOR 0.88 (0.41–1.88), p = 0.74], or rehospitalizations [49.4% vs. 44.4%, aOR 1.24 (0.78–1.98), p = 0.36]. Patients with SVT as an exclusive trigger presented more 1-year rehospitalizations [52.8% vs. 43.3%, aOR 3.74 (1.05–10.5), p = 0.01].ConclusionSVT is a frequent trigger of CS alone or in association in more than 10% of miscellaneous CS cases. Although SVT-triggered CS patients were more comorbid with more pre-existing cardiomyopathies and HF incidences, they presented similar rates of mortality, HTx, and VAD at 1 year, arguing for a better overall prognosis.Clinical Trial Registrationhttps://clinicaltrials.gov, identifier: NCT02703038.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1167738/fullcardiogenic shocksupraventricular tachycardiaepidemiologyprognosismortality
spellingShingle Miloud Cherbi
Miloud Cherbi
Eric Bonnefoy
Nicolas Lamblin
Edouard Gerbaud
Edouard Gerbaud
Laurent Bonello
Laurent Bonello
Laurent Bonello
François Roubille
Bruno Levy
Sebastien Champion
Pascal Lim
Pascal Lim
Francis Schneider
Meyer Elbaz
Meyer Elbaz
Hadi Khachab
Jeremy Bourenne
Marie-France Seronde
Guillaume Schurtz
Brahim Harbaoui
Brahim Harbaoui
Gerald Vanzetto
Nicolas Combaret
Vincent Labbe
Benjamin Marchandot
Benoit Lattuca
Caroline Biendel-Picquet
Caroline Biendel-Picquet
Guillaume Leurent
Etienne Puymirat
Etienne Puymirat
Philippe Maury
Philippe Maury
Clément Delmas
Clément Delmas
Clément Delmas
One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
Frontiers in Cardiovascular Medicine
cardiogenic shock
supraventricular tachycardia
epidemiology
prognosis
mortality
title One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
title_full One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
title_fullStr One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
title_full_unstemmed One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
title_short One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
title_sort one year outcomes in cardiogenic shock triggered by supraventricular tachycardia an analysis of the frenshock multicenter prospective registry
topic cardiogenic shock
supraventricular tachycardia
epidemiology
prognosis
mortality
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1167738/full
work_keys_str_mv AT miloudcherbi oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT miloudcherbi oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT ericbonnefoy oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT nicolaslamblin oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT edouardgerbaud oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT edouardgerbaud oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT laurentbonello oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT laurentbonello oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT laurentbonello oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT francoisroubille oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT brunolevy oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT sebastienchampion oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT pascallim oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT pascallim oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT francisschneider oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT meyerelbaz oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT meyerelbaz oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT hadikhachab oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT jeremybourenne oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT mariefranceseronde oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT guillaumeschurtz oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT brahimharbaoui oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT brahimharbaoui oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT geraldvanzetto oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT nicolascombaret oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT vincentlabbe oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT benjaminmarchandot oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT benoitlattuca oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT carolinebiendelpicquet oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT carolinebiendelpicquet oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT guillaumeleurent oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT etiennepuymirat oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT etiennepuymirat oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT philippemaury oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT philippemaury oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT clementdelmas oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT clementdelmas oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry
AT clementdelmas oneyearoutcomesincardiogenicshocktriggeredbysupraventriculartachycardiaananalysisofthefrenshockmulticenterprospectiveregistry